Skip to content
DraconiticResearch
Search Sources API
174,684 studies31 sourcesUpdated 1 h ago

Pharmacology & toxicology

2,551 studies307 in 7 days1,366 in 30 days

Filters
Type
Date
Clear

Latest

2,587 studies

  1. Strategic selection of TPD technologies based on disease pathology: from mechanistic diversity to clinical implementation
    Dongxin Yi, Jingyuan Zhao, Shuai Li +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  2. Multidimensional analysis of the pathological mechanisms of infantile hemangioma: metabolic reprogramming, immune remodeling, and programmed cell death
    Haoyi Liang, Haizhou Pan, Yangjinyi An +6
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  3. Traditional Paeonia radix alba formulas and their bioactive metabolites: a narrative review focusing on hepatoprotection in chronic liver diseases
    Yanqi Li, Jinmin Shen, Xiaozhong He +7
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  4. Editorial: 4Rs in ethnopharmacology - reduce, refine, replace and responsibility using animal models
    Aiping Lyu, Xiaojuan He, Michael Heinrich +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  5. Progression-free survival of 23 months with second-line trastuzumab deruxtecan in HER2-positive gastroesophageal junction adenocarcinoma: a case report
    Yuanmei Dong, Li Zhang, Lan Zhao +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  6. Justicia procumbens suppresses high-fat diet-induced weight gain in mice and adipogenesis in 3T3-L1 cells with inhibition of AKT and STAT3 phosphorylation
    Yeeun Kim, Seoyeon Lee, Jun Hyung Park +10
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  7. A tumor-responsive nanoplatform orchestrating multiplexed macrophage engagers and immune checkpoint blockade for triple-negative breast cancer immunotherapy
    Bo Xiang, Tao Liu, Wei Wang +3
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyCrossref
  8. Tanshinone IIA in colorectal cancer: preclinical mechanisms, therapeutic sensitization, and translational prospects
    Siqin Li, Jingzhi Zhang, Xiaoyu Zhang +6
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  9. Sulodexide versus low-molecular-weight heparin in critically ill neonates: a propensity score–matched retrospective cohort study
    Mengsha Wei, Yuanguo Xiong, Fan Zhang +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  10. Effect of compound kushen injection on immune function in patients with lung cancer: a systematic review and meta-analysis
    Yu Xiong, Yutong Cai, Lin Wang +5
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  11. Oral anticoagulants and the risk of acute kidney injury: a retrospective real-world cohort study using overlap propensity score weighting
    Ping Li, Fang-Yuan Tian, Hao-Bo Liu +4
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  12. Paeoniflorin ameliorates Parkinson’s disease by promoting autophagy to inhibit A1 phenotype astrocyte activation
    Yijiao Long, Lihui Wang, Jun Yin +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  13. Engineering a multifunctional LL37-TP5 hybrid peptide with potent antimicrobial endotoxin-neutralizing and anti-inflammatory properties
    Baseer Ahmad, Kiran Khurshid, Wei Xubiao +5
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  14. Human amniotic mesenchymal stem cell-derived exosomes alleviate cerebral Palsy–Associated neuronal damage via TSC1/mTOR/ULK1 autophagy suppression and PINK1/Parkin mitophagy restoration
    Yu Zhou, Fuli Yan, Zhouzhou Li +3
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  15. Review of oregano essential oils: pharmacological activities and applications
    Lei Tao, Xinsheng Wang, Xiaodong Wang +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  16. From recognition to delivery: nucleic acid aptamers in miRNA-related diagnosis and therapy of hepatocellular carcinoma
    Shihao Du, Shaokang Wu, Ruomiao Li +2
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  17. Magnesium cantharidate suppresses hepatocellular carcinoma progression and modulates tumor-associated macrophage polarization: potential involvement of ERK1/2 signaling and de novo serine synthesis
    Zhenfu Chen, Liu Liu, Sali Li +4
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  18. Development and qualification of recombinant Göttingen Minipig CYP3A22 and CYP3A29
    Laura Buyssens, Alexandra Kiss, Miriam Ayuso +7
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  19. Patterns of proton pump inhibitor prescription: a retrospective study from a tertiary hospital in Saudi Arabia
    Yousef Saeed Alqarni
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  20. Integrated transcriptomic and proteomic profiling of RXRA-overexpressing chronic myeloid leukemia cells identifies protein kinase D as a candidate target for imatinib sensitization
    Rakhi Thalayattu Vidhyadharan, Raveen Stephen Stallon Illangeswaran, Bharathi M. Rajamani +7
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  21. Raddeanin A is associated with enhanced anti-tumor efficacy of doxorubicin in a murine breast cancer model by modulating MDR1 expression
    Lishan Hui, Nanding Wu, Qixuan Sun +4
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiers
  22. Crosstalk between Nrf2 and miRNAs in oxidative stress, cancer progression, and therapy resistance
    Nexhibe Nuhii, Sarmistha Saha, Brigitta Buttari +4
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  23. Single-cell RNA sequencing identifies stem-like subpopulations and their gene signature in lung adenocarcinoma progression
    Lijuan Shao, Jiali Guo, Yujia Chen +8
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  24. Protective effects and underlying mechanisms of naringenin in myocardial ischemia/reperfusion injury: a systematic review and preclinical meta-analysis
    Zuoyun He, Na Xie, Xupeng Shao +10
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  25. PD-1 and its ligands in ILC2-mediated airway inflammation in asthma: context-dependent mechanisms and therapeutic implications
    Liu Ma, Mingrong Zhang, Shengdong Gou +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiers